The method has been described in our previous research [46]. For the evaluation of P-gp ATPase activity of caffeic acid, Pgp-GloTM Assay System from Promega (Madison, WI, USA) was used. In a 96-well untreated white plate, 25 μg of recombinant human P-gp membranes were incubated with Pgp-GloTM Assay Buffer (untreated control), 200 μM verapamil (positive control for drug induced P-gp ATPase activity), 100 μM sodium orthovanadate (selective inhibitor for P-gp ATPase activity), or a series of concentrations of caffeic acid. The reaction was initiated by adding 5 mM MgATP and incubated for 40 min at 37 °C, followed by stopping the reaction with 50 μL ATPase Detection Reagent for 20 min at room temperature. Luminescence was measured using a BioTek Synergy HT Multi-Mode Microplate Reader, and data were presented as Change in Luminescence (ΔRLU).
Do you have any questions about this protocol?
Post your question to gather feedback from the community. We will also invite the authors of this article to respond.